Design, Synthesis, and Pharmacokinetic Evaluation of a Chemical Delivery System for Drug Targeting to Lung Tissue
We espouse the application of a novel chemical delivery system (CDS) approach to a delivery mechanism for drug targeting to lung tissue using the 1,2-dithiolane-3-pentyl moiety of lipoic acid as the “targetor moiety”. The synthesis and the physicochemical and pharma-cokinetic evaluation of a CDS mod...
Saved in:
Published in | Journal of pharmaceutical sciences Vol. 85; no. 5; pp. 496 - 504 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Elsevier Inc
01.05.1996
John Wiley & Sons, Inc AMER PHARMACEUTICAL ASSN Wiley American Pharmaceutical Association |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We espouse the application of a novel chemical delivery system (CDS) approach to a delivery mechanism for drug targeting to lung tissue using the 1,2-dithiolane-3-pentyl moiety of lipoic acid as the “targetor moiety”. The synthesis and the physicochemical and pharma-cokinetic evaluation of a CDS modeling the lipoyl and other ester derivatives of chlorambucil (an antineoplastic agent) and cromolyn (a bischromone used in antiasthma prophylaxis) as compared with their respective parent drugs are described. The chlorambucil CDS was synthesized by esterifying the alcohol derivative of lipoic acid with chlorambucil using dicyclohexylcarbodiimide as the coupling agent. The cromolyn CDS was prepared by a multistep synthetic procedure culminating in the reaction of the alkyl bromide derivative of lipoic acid with the disodium salt of the bischromone compound. All the esters were highly lipophilic unlike the parent compounds. The in-vitro kinetic and in-vivo pharmacokinetic studies showed that the respective CDSs were sufficiently stable in buffer and biological media, hydrolyzed rapidly into the respective active parent drugs, and significantly enhanced delivery and retention of the active compound to lung tissue in comparison with the underivatized parent compounds used in conventional therapy. |
---|---|
Bibliography: | ark:/67375/WNG-1CKKGK5L-M istex:22A4369BA73D52E7C2EE3F920F0B90D68987DC1B ArticleID:JPS8 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0022-3549 1520-6017 |
DOI: | 10.1021/js9504200 |